PJP · Invesco Pharmaceuticals ETF
Invesco Exchange-Traded Fund Trust
$125.76
-0.51%
At close · Oct 21
Net assets $472,102,031
Holdings33
1 month
+0.24%
Year to date
+21.26%
52-week range
$94.66–$131.68
30-session avg volume
36,687
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Open-end / ETF
- SEC series
- S000003031
- Report date
- Jul 31, 2026
- Holdings coverage
- Full reported portfolio
Portfolio concentration
Top 10 holdings53.65%
Calculated only when the SEC filing is stored with complete portfolio coverage.
Asset allocation
EC99.92%
STIV11.76%
Country allocation
US106.45%
IE5.24%
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| Invesco Private Prime Fund | $37,427,423 | 7.93% | |
| Abbott Laboratories | ABT | $26,775,607 | 5.67% |
| AbbVie Inc. | ABBV | $25,856,356 | 5.48% |
| Amgen Inc. | AMGN | $25,173,672 | 5.33% |
| Johnson & Johnson | JNJ | $24,448,869 | 5.18% |
| Merck & Co., Inc. | MRK | $23,873,863 | 5.06% |
| Eli Lilly and Co. | LLY | $23,691,378 | 5.02% |
| Corcept Therapeutics Inc. | CORT | $23,426,715 | 4.96% |
| Gilead Sciences, Inc. | GILD | $21,378,138 | 4.53% |
| Pfizer Inc. | PFE | $21,242,319 | 4.50% |
| Amneal Pharmaceuticals, Inc. | AMRX | $17,688,784 | 3.75% |
| Invesco Private Government Fund | $17,629,582 | 3.73% | |
| Liquidia Corp. | LQDA | $17,283,932 | 3.66% |
| Travere Therapeutics, Inc. | TVTX | $15,586,380 | 3.30% |
| Ligand Pharmaceuticals Inc. | LGND | $15,092,975 | 3.20% |
| Regeneron Pharmaceuticals, Inc. | REGN | $14,840,780 | 3.14% |
| Harmony Biosciences Holdings, Inc. | HRMY | $14,464,188 | 3.06% |
| Bristol-Myers Squibb Co. | BMY | $13,899,470 | 2.94% |
| Viatris Inc. | VTRS | $13,337,399 | 2.83% |
| Jazz Pharmaceuticals PLC | JAZZ | $13,160,604 | 2.79% |
| Biogen Inc. | BIIB | $12,974,391 | 2.75% |
| Collegium Pharmaceutical, Inc. | COLL | $12,939,716 | 2.74% |
| Prestige Consumer Healthcare Inc. | PBH | $12,915,831 | 2.74% |
| Ocular Therapeutix, Inc. | OCUL | $12,170,759 | 2.58% |
| ANI Pharmaceuticals, Inc. | ANIP | $12,021,659 | 2.55% |
| Tarsus Pharmaceuticals, Inc. | TARS | $11,921,947 | 2.53% |
| Perrigo Co. PLC | PRGO | $11,561,058 | 2.45% |
| Supernus Pharmaceuticals, Inc. | SUPN | $11,536,766 | 2.44% |
| Innoviva, Inc. | INVA | $11,418,081 | 2.42% |
| United Therapeutics Corp. | UTHR | $11,058,803 | 2.34% |
| Invesco Government & Agency Portfolio | 825252885 | $474,555 | 0.10% |
| OmniAb, Inc. | 68218J301 | $0 | 0.00% |
| OmniAb, Inc. | 68218J202 | $0 | 0.00% |